Shares of GSX Techedu (NYSE: GSX) were 9% higher in midday trading Monday on no news that really should have caused the stock to rise. It filed its annual report with the Securities and Exchange Commission (it reported results back in early March) and announced it was changing its stock ticker symbol on the NYSE from GSX to GOTU.
What is GSX techedu's stock symbol?
GSX Techedu trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSX." Who are GSX Techedu's major shareholders? GSX Techedu's stock is owned by a variety of retail and institutional investors.
What is the target price for GSX techedu?
Their forecasts range from $37.00 to $76.00. On average, they anticipate GSX Techedu's stock price to reach $60.40 in the next year. This suggests a possible upside of 2,670.6% from the stock's current price. View analysts' price targets for GSX Techedu or view top-rated stocks among Wall Street analysts. Who are GSX Techedu's key executives?
Who sold GSX stock in the last quarter?
GSX stock was sold by a variety of institutional investors in the last quarter, including Simplex Trading LLC, IMC Chicago LLC, Cutler Group LP, and XR Securities LLC.
How much did (GSX) raise from its IPO?
(GSX) raised $208 million in an IPO on Thursday, June 6th 2019. The company issued 19,800,000 shares at a price of $9.50-$11.50 per share. Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays and CLSA were co-managers.
What is GSX new ticker?
GSX:US has changed to a new ticker symbol: GOTU:US.
Why did Gaotu Techedu stock drop?
Following the crackdown on Chinese tutoring stocks last year as the Chinese government banned them from making a profit on most of their tutoring services directed at children, Gaotu Techedu is down a whopping 98.5% from its peak roughly a year ago.
Is GSX a good stock?
Community Sentiment. GSX Techedu has received 59.63% “outperform” votes from our community.
Will GOTU stock recover?
On average, Wall Street analysts predict that Gaotu Techedu's share price could reach $3.05 by Jul 26, 2022. The average Gaotu Techedu stock price prediction forecasts a potential upside of 55.61% from the current GOTU share price of $1.96.
Is Gotu stock a buy?
Gaotu Techedu Inc (NYSE:GOTU) The 1 analysts offering 12-month price forecasts for Gaotu Techedu Inc have a median target of 1.99, with a high estimate of 1.99 and a low estimate of 1.99. The median estimate represents a +1.67% increase from the last price of 1.96.
How do you buy stocks on wish?
Shares of WISH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How can I buy stock in GSX?
How to buy shares in GSX TecheduCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is GSX an ADR?
Gsx Techedu Inc ADR (GSX)
Who is buying Gotu stock?
Top 10 Owners of Gaotu Techedu IncStockholderStakeShares bought / soldCredit Suisse International (Inve...1.55%+120,917Krane Funds Advisors LLC1.48%+677,487BlackRock Fund Advisors1.38%-2,633HSBC Global Asset Management (UK)...1.23%-9,7446 more rows
How were GSX Techedu's earnings last quarter?
GSX Techedu Inc. (NYSE:GSX) issued its quarterly earnings data on Thursday, March, 4th. The company reported ($2.29) earnings per share (EPS) for t...
Who are GSX Techedu's key executives?
GSX Techedu's management team includes the following people: Mr. Xiangdong Chen , Chairman & CEO (Age 49) Ms. Nan Shen , Chief Financial Office...
Who are some of GSX Techedu's key competitors?
Some companies that are related to GSX Techedu include Strategic Education (STRA) , Stride (LRN) , Adtalem Global Education (ATGE) , Afya (AFYA...
What other stocks do shareholders of GSX Techedu own?
Based on aggregate information from My MarketBeat watchlists, some companies that other GSX Techedu investors own include Advanced Micro Devices (...
When did GSX Techedu IPO?
(GSX) raised $208 million in an initial public offering (IPO) on Thursday, June 6th 2019. The company issued 19,800,000 shares at a price of $9.50-...
What is GSX Techedu's stock symbol?
GSX Techedu trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSX."
What is GSX Techedu's stock price today?
One share of GSX stock can currently be purchased for approximately $1.79.
How much money does GSX Techedu make?
GSX Techedu (NYSE:GSX) has a market capitalization of $427.03 million and generates $303.78 million in revenue each year. The company earns $32.56...
How many employees does GSX Techedu have?
GSX Techedu employs 6,435 workers across the globe.
What is the strongest trend for GSX?
The strongest trend for GSX is in Momentum, which has been heading down over the past 198 days. GSX's current lowest rank is in the Sentiment metric (where it is better than 0.86% of US stocks).
What is GSX 20-F?
GSX Techedu Inc. (the "Company") (NYSE: GSX), a leading online K-12 large-class after-school tutoring service provider in China, today filed with the U.S. Securities and Exchange Commission its annual report on Form 20-F for the fiscal year ended December 31, 2020.
What happened
Shares of Chinese online after-school tutoring stock Gaotu Techedu (NYSE: GOTU), which changed its name from "GSX Techedu" last week, closed down 9% on Friday after investment bank Citigroup downgraded the stock all the way from buy to sell.
So what
According to Citi, Chinese news site Xinhua Net quoted Chinese President Xi Jinping commenting that "students should not rely for their studies on after-school tutoring."
Now what
The next steps, warns Citi in a note covered today on TheFly.com, could be for Chinese regulators to impose controls on "excessive capitalization," put caps on pricing, ban advertising of tutoring services, and perhaps even restrict tutoring sessions to weekends and holidays.
What happened
The coronavirus is getting worse in China, and it's possible that investors believe that's a good thing for GSX Techedu ( GOTU -0.46% ). The company is a remote-education company in China, and its business grew substantially in 2020. And if COVID-19 gets worse in that country, it's possible 2021 will be another good year for this business.
So what
According to The Associated Press, new coronavirus cases are causing the Chinese government to lock down two hospitals in Shanghai. Parts of Beijing are also locking down. The government is reportedly hoping to have 50 million people vaccinated over the next few weeks, a small fraction of the country's 1.4 billion population.
NYSE: GOTU
But that would only be 122% to 126% year-over-year revenue growth -- still stellar but a big pullback from the growth rate it experienced in 2020, perhaps reflecting the return to normal in China as the pandemic seemed to be dying out.
Now what
Here's why so many shares of GSX Techedu are sold short to begin with: the company is under fire from many popular short-sellers, who claim GSX Techedu is a fraud.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
AstraZeneca (AZN) Enhertu Effective in HER2-Low Breast Cancer
AstraZeneca's (AZN) DESTINY-Breast04 is the first-ever phase III study of a HER2-directed therapy to show a statistically significant and clinically meaningful survival benefit in patients with HER2-low metastatic breast cancer.
GSK to name consumer healthcare unit 'Haleon' after spin-off
The British group, which had rejected Unilever's 50 billion pound ($68 billion) bid for the consumer healthcare business in December, said it plans to unveil more details at an investor event at the end of the month. Pfizer owns the remaining 32%.
Moderna Is Targeting Shingles, Herpes, and Cancer. The CEO Is Looking Beyond Covid
CEO Stéphane Bancel said the company is confident enough, and has enough capital, for a big study that would bring the vaccine to market faster.
Sage Therapeutics (SAGE) Depression Drug Meets Goal, Stock Down
Sage Therapeutics (SAGE) and Biogen's (BIIB) depression candidate, zuranolone given along with antidepressants improves depressive symptoms in a phase III study. Questions remain about the durability of the drug.
AstraZeneca's (AZN) Lupus Drug Saphnelo Gets Europe Nod
AstraZeneca's (AZN) Saphnelo is the only new biologic to be approved in Europe in over a decade for patients with systemic lupus erythematosus.
Baxter (BAX) Q4 Earnings and Revenues Surpass Estimates
Baxter's (BAX) fourth-quarter results reflect robust performance across six of its business units.
West Pharmaceutical (WST) Q4 Earnings & Revenues Top Estimates
West Pharmaceutical's (WST) fourth-quarter earnings reflect strength in the Proprietary Products segment and margin expansion.
Quick Reminder: Many Stock youtubers have financial incentive to keep you watching daily so they steer you toward short term trades
If they told you invest in an index fund or buy and hold the best of FAANG+MSFT/NVDA. There would be no reason to watch their videos daily. Or their market open and close live streams. The views are how they make their money. Meet Kevin for example makes millions each month off the views.
What is your plan to profit from Evergrande collapse?
Quick summary: Evergrande is a real-estate developer from China that has $305 billion of liabilities and cannot pay of their debt. They are not the only company though, other real-estate companies are also facing liquidity problems and it looks like the property bubble in China is collapsing.
Powell orders ethics review after Fed presidents disclosed multimillion-dollar investments
I'm sure Powell will make it so Fed presidents can't profit from their positions. /s
How would you manage 500k USD?
Imagine you get 500k USD. Assume it's all your net worth and you don't have other assets like property, just a job with a monthly income of $ 3,500 after taxes.
